ISSN : 2663-2187

Pazopanib: Effective monotherapy for precise cancer treatment, targeting specific mutations and tumors

Main Article Content

Rashmi Pathak, Virender Kaur2, Surabhi Sharma1, Maulshree Bhandari, Riya Mishra, Archita Saxena, Arpita Upreti, Himanshu Sharma
ยป doi: 10.33472/AFJBS.6.9.2024.1311-1330

Abstract

Cancer is a wide range of illnesses characterized by the expansion of abnormal cells with the ability to invade and damage healthy bodily tissue. Cancer is treated with a variety of chemotherapy or chemo medicines, Busulfan, and the alkylating agent. Soft tissue sarcoma is the uncommon kind that occurs in the tissues that encircle, link, and support other body structures. This includes the lining of your joints, blood vessels, muscles, and blood vessels. The soft tissue sarcoma family includes 50 subtypes. Pazopanib is used to treat specific cancers (soft tissue sarcoma). Tyrosine kinase inhibitors are a class of medications that includes pazopanib. Pazopanib treatment for soft tissue sarcoma and its mode of action are the current areas of emphasis.

Article Details